|
Donald S. Karanewsky, Ph.D., Senior Vice President, Discovery, joined Senomyx in June 2007. Dr. Karanewsky has directed chemistry research teams and had senior management roles at a number of biotechnology institutions including Idun Pharmaceuticals, Ligand Pharmaceuticals and most recently, The Genomics Institute of the Novartis Research Foundation (GNF). In addition, he held principal positions at Glaxo Inc, Bristol-Myers Squibb, and the Squibb Institute for Medical Research. He received his Ph.D. in Chemistry from Harvard University and was granted a B.S. in Chemistry, Magna Cum Laude, from Stevens Institute of Technology in New Jersey. Dr. Karanewsky is an inventor on more than 70 issued US patents and has authored over 50 scientific publications. | 